Tri-Specific NK Cell ENGAGERS (TriKE®) Targeted NK Cell Therapies to Treat Cancer and Autoimmune Disease GT Biopharma (Nasdaq: GTBP) Corporate Presentation – May 2025 Disclaimer This presentation includes statements that are, or may be deemed, "forward-looking statements." In some cases, you can identify forward-looking statements by terminology including "anticipates," "believes," "can," "continue," "could," "estimates," "expects," "intends," "may," "plans," "potential," "predicts," "should," "will," "woul ...